Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,806 | 15,146 | 20,958 | 13,890 | 11,092 |
| Receivables | 92,867 | 93,457 | 109,998 | 132,771 | 138,106 |
| Inventories | 38,151 | 42,908 | 41,528 | 52,263 | 50,163 |
| Other current assets | 6,227 | 6,060 | 6,292 | 6,455 | 5,925 |
| TOTAL | $165,848 | $169,889 | $191,393 | $219,707 | $221,237 |
| Non-Current Assets | |||||
| PPE Net | 115,293 | 117,123 | 119,866 | 123,112 | 123,506 |
| Intangibles | 108,028 | 108,096 | 108,188 | 108,349 | 0 |
| Other Non-Current Assets | 179,410 | 195,706 | 194,994 | 195,441 | 429,930 |
| TOTAL | $402,731 | $420,925 | $423,048 | $426,902 | $553,436 |
| Total Assets | $568,579 | $590,814 | $614,441 | $646,609 | $774,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 75,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 23,028 | 22,806 | 23,693 | 37,054 | 35,611 |
| Accrued Expenses | 26,526 | 33,473 | 34,663 | 28,563 | 26,689 |
| Other current liabilities | 8,399 | 8,149 | 9,448 | 8,112 | 9,382 |
| TOTAL | $89,750 | $172,136 | $99,284 | $108,447 | $111,594 |
| Non-Current Liabilities | |||||
| Long Term Debt | 259,433 | 189,566 | 286,610 | 302,420 | 305,283 |
| Deferred Revenues | 5,457 | 8,021 | 10,513 | 11,210 | 13,381 |
| Other Non-Current Liabilities | 123,255 | 135,418 | 138,082 | 141,714 | 148,358 |
| TOTAL | $403,256 | $346,969 | $449,010 | $468,088 | $480,939 |
| Total Liabilities | $493,006 | $519,105 | $548,294 | $576,535 | $592,533 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,574 | 44,495 | 44,484 | 44,457 | 44,446 |
| Common Shares | 1,148 | 1,148 | 1,148 | 1,148 | 1,148 |
| Retained earnings | 50,456 | 37,364 | 34,846 | 41,007 | 160,539 |
| Other shareholders' equity | -3,215 | -4,268 | -4,748 | -4,063 | -2,419 |
| TOTAL | $75,573 | $71,709 | $66,147 | $70,074 | $182,140 |
| Total Liabilities And Equity | $568,579 | $590,814 | $614,441 | $646,609 | $774,673 |